These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27016034)

  • 21. Citalopram elicits a discriminative stimulus in rats at a dose selectively increasing extracellular levels of serotonin vs. dopamine and noradrenaline.
    Millan MJ; Gobert A; Girardon S; Dekeyne A
    Eur J Pharmacol; 1999 Jan; 364(2-3):147-50. PubMed ID: 9932717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lasting neurobehavioral abnormalities in rats after neonatal activation of serotonin 1A and 1B receptors: possible mechanisms for serotonin dysfunction in autistic spectrum disorders.
    Khatri N; Simpson KL; Lin RC; Paul IA
    Psychopharmacology (Berl); 2014 Mar; 231(6):1191-200. PubMed ID: 23975037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo.
    Auerbach SB; Hjorth S
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):597-606. PubMed ID: 9053730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
    Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
    Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain.
    Ortega JE; Gonzalez-Lira V; Horrillo I; Herrera-Marschitz M; Callado LF; Meana JJ
    Eur J Pharmacol; 2013 Jun; 709(1-3):13-9. PubMed ID: 23562616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanisms of action of antidepressants: new data from Escitalopram].
    Fabre V; Hamon M
    Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal exposure to citalopram selectively alters the expression of the serotonin transporter in the hippocampus: dose-dependent effects.
    Weaver KJ; Paul IA; Lin RC; Simpson KL
    Anat Rec (Hoboken); 2010 Nov; 293(11):1920-32. PubMed ID: 20830689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of hippocampal excitability by citalopram.
    Igelström KM; Heyward PM
    Epilepsia; 2012 Nov; 53(11):2034-42. PubMed ID: 22946760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial 5-HT1A receptor agonist properties of (-)pindolol in combination with citalopram on serotonergic dorsal raphe cell firing in vivo.
    Arborelius L; Linnér L; Wallsten C; Ahlenius S; Svensson TH
    Psychopharmacology (Berl); 2000 Jul; 151(1):77-84. PubMed ID: 10958120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat.
    Björkholm C; Frånberg O; Malmerfelt A; Marcus MM; Konradsson-Geuken Å; Schilström B; Jardemark K; Svensson TH
    Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Target brain sites of the anxiolytic effect of citalopram, a selective serotonin reuptake inhibitor.
    Izumi T; Inoue T; Kitaichi Y; Nakagawa S; Koyama T
    Eur J Pharmacol; 2006 Mar; 534(1-3):129-32. PubMed ID: 16494863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Removal of GABAergic inhibition alters subthreshold input in neurons in forepaw barrel subfield (FBS) in rat first somatosensory cortex (SI) after digit stimulation.
    Li CX; Callaway JC; Waters RS
    Exp Brain Res; 2002 Aug; 145(4):411-28. PubMed ID: 12172653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area.
    Dremencov E; El Mansari M; Blier P
    J Psychiatry Neurosci; 2009 May; 34(3):223-9. PubMed ID: 19448853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats.
    Gobbi M; Crespi D; Foddi MC; Fracasso C; Mancini L; Parotti L; Mennini T
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):22-8. PubMed ID: 9228186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal exposure to citalopram, a serotonin selective reuptake inhibitor, programs a delay in the reflex ontogeny in rats.
    Deiró TC; Carvalho J; Nascimento E; Medeiros JM; Cajuhi F; Ferraz-Pereira KN; Manhães-de-Castro R
    Arq Neuropsiquiatr; 2008 Sep; 66(3B):736-40. PubMed ID: 18949273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity-dependent presynaptic effect of serotonin 1B receptors on the somatosensory thalamocortical transmission in neonatal mice.
    Laurent A; Goaillard JM; Cases O; Lebrand C; Gaspar P; Ropert N
    J Neurosci; 2002 Feb; 22(3):886-900. PubMed ID: 11826118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effect of local infusion of serotonin reuptake inhibitors in the raphe versus forebrain and the role of depolarization-induced release in increased extracellular serotonin.
    Tao R; Ma Z; Auerbach SB
    J Pharmacol Exp Ther; 2000 Aug; 294(2):571-9. PubMed ID: 10900234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor.
    Hjorth S; Westlin D; Bengtsson HJ
    Neuropharmacology; 1997; 36(4-5):461-5. PubMed ID: 9225270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of 5-hydroxytryptamine reuptake by the antidepressant citalopram in the locus coeruleus modulates the rat brain noradrenergic transmission in vivo.
    Mateo Y; Ruiz-Ortega JA; Pineda J; Ugedo L; Meana JJ
    Neuropharmacology; 2000 Aug; 39(11):2036-43. PubMed ID: 10963747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.